Description
Product introduction
Clavam 625 Tablet is an antibiotic that helps your body fight infections caused by bacteria. It is used to treat infections of the lungs (e.g., pneumonia), the ear, the nasal sinus, the urinary tract, the skin, and the soft tissue. It will not work for viral infections such as the common cold.
Clavam 625 Tablet is best taken with a meal to reduce the chance of a stomach upset. You should take it regularly at evenly spaced intervals as per the schedule prescribed by your doctor. Taking it at the same time daily will help you remember to take it. The dose will depend on what you are being treated for, but you should always complete an entire course of this antibiotic as your doctor prescribes. Please do not stop taking it until you have finished, even when you feel better. If you stop taking it early, some bacteria may survive, and the infection may return or worsen.
The most common side effects of Clavam 625 Tablet include recurrent or persistent fungal infection (mucocutaneous candidiasis), nausea, diarrhea, and vomiting. If you experience any side effects that are persistent or worsen, consult your doctor for guidance.
Before taking it, let your doctor know if you are allergic to any antibiotics or have kidney or liver problems. You should also inform your doctor about all other medicines you are taking, as they may affect or be affected by Clavam 625 Tablet. Pregnant and breastfeeding women should consult their doctor before using this medicine to make sure it is safe.
Uses of Clavam Tablet
- Treatment of Bacterial Infection
Benefits of Clavam Tablet
In Treatment of Bacterial infections
Side effects of Clavam Tablet
Common side effects of Clavam
- Mucocutaneous candidiasis
- Diarrhea
- Nausea
- Vomiting
How to use Clavam Tablet
How Clavam Tablet works
Safety advice
Pregnancy
Use of this medicine is not recommended in patients with severe kidney disease.
Liver CAUTION
Regular monitoring of liver function tests is recommended while you are taking this medicine
Reviews
There are no reviews yet.